Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her-2/neu antigen

This publication has 21 references indexed in Scilit:

• Suppression and promotion of tumor growth by monoclonal antibodies to ErbB-2 differentially correlate with cellular uptake.
  Proceedings of the National Academy of Sciences, 1995
• Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group.
  Journal of Clinical Oncology, 1993
• Inhibition of Human Lung Cancer Cell Line Growth by an Anti-p185^HER2 Antibody
  American Journal of Respiratory Cell and Molecular Biology, 1993
• Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
  Science, 1989
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987
• The Product of the Human c- erb B-2 Gene: a 185-Kilodalton Glycoprotein with Tyrosine Kinase Activity
  Science, 1986
• p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
  Molecular and Cellular Biology, 1986
• The neu oncogene encodes an epidermal growth factor receptor-related protein
  Nature, 1986
• Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene
  Science, 1985
• Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies
  Cell, 1985